The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Crinetics Pharmaceuticals, Inc(NASDAQ:CRNX) 
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin recept...
Website: http://www.crinetics.com
Founded: 2008
Full Time Employees: 68
Founder: R. Scott Struthers, Stephen F. Betz, Ana Kusnetzow, and Yun-Fei Zhu
CEO: R. Scott Struthers
Sector: Healthcare
Industry: Biotechnology
Crinetics Pharmaceuticals Days Payable Outstanding ttm (DPO)
Crinetics Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Crinetics Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Crinetics Pharmaceuticals Op Cashflow Per Share ttm
Crinetics Pharmaceuticals Free Cashflow Per Share ttm
Crinetics Pharmaceuticals Cash Per Share ttm
Crinetics Pharmaceuticals P/S ratio ttm
Crinetics Pharmaceuticals (GAAP) P/E ratio ttm
Crinetics Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.